|
DE1643310A1
(de)
|
1966-12-29 |
1971-06-03 |
Dow Chemical Co |
4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
|
|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
DE2926517A1
(de)
|
1979-06-30 |
1981-01-15 |
Beiersdorf Ag |
Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
US4366158A
(en)
|
1979-11-30 |
1982-12-28 |
Burroughs Wellcome Co. |
1-(8-Quinolyl)-2-pyrrolidone and its pharmaceutical compositions
|
|
IL61721A
(en)
|
1980-12-16 |
1984-03-30 |
Blank Izhak |
Nitroglycerin preparations
|
|
US4555399A
(en)
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
|
US4985352A
(en)
|
1988-02-29 |
1991-01-15 |
The Trustees Of Columbia University In The City Of New York |
DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
JPH02262627A
(ja)
|
1988-12-08 |
1990-10-25 |
Japan Synthetic Rubber Co Ltd |
有機非線形光学素子
|
|
JPH03135978A
(ja)
|
1989-08-08 |
1991-06-10 |
Merck Sharp & Dohme Ltd |
置換ピリジン、その製法、処方並びに痴呆症における使用法
|
|
US5661024A
(en)
|
1989-10-31 |
1997-08-26 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
|
|
US5128351A
(en)
|
1990-05-04 |
1992-07-07 |
American Cyanamid Company |
Bis-aryl amide and urea antagonists of platelet activating factor
|
|
US5077409A
(en)
|
1990-05-04 |
1991-12-31 |
American Cyanamid Company |
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
|
|
JPH04334357A
(ja)
|
1991-05-02 |
1992-11-20 |
Fujirebio Inc |
酵素阻害作用を有するアシル誘導体
|
|
FR2682379B1
(fr)
|
1991-10-09 |
1994-02-11 |
Rhone Poulenc Agrochimie |
Nouveaux phenylpyrazoles fongicides.
|
|
FR2690440B1
(fr)
|
1992-04-27 |
1995-05-19 |
Rhone Poulenc Agrochimie |
Arylpyrazoles fongicides.
|
|
GB9300147D0
(en)
|
1993-01-06 |
1993-03-03 |
Minnesota Mining & Mfg |
Photothermographic materials
|
|
GB9311790D0
(en)
|
1993-06-08 |
1993-07-28 |
Minnesota Mining & Mfg |
Photothermographic materials
|
|
JPH09504004A
(ja)
|
1993-08-20 |
1997-04-22 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
５ｈｔ１ｄレセプター拮抗薬用アミドおよび尿素誘導体
|
|
US5596001A
(en)
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
|
DK122693D0
(da)
|
1993-10-29 |
1993-10-29 |
Hempels Skibsfarve Fab J C |
Marin struktur
|
|
FR2722369B1
(fr)
|
1994-07-13 |
1998-07-10 |
Rhone Poulenc Agrochimie |
Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
|
|
KR970706242A
(ko)
|
1994-10-04 |
1997-11-03 |
후지야마 아키라 |
우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors)
|
|
CA2135253A1
(en)
|
1994-11-07 |
1996-05-08 |
Michael Dennis |
Compound screening based on a window of chemical-messenger-independent activity
|
|
CN1151147C
(zh)
|
1995-02-02 |
2004-05-26 |
史密丝克莱恩比彻姆有限公司 |
作为5-ht受体拮抗剂的吲哚衍生物
|
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
|
US5576338A
(en)
|
1995-02-15 |
1996-11-19 |
Merck Frosst Canada, Inc. |
Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis
|
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2218486A1
(en)
|
1995-04-20 |
1996-10-24 |
Vectorpharma - Eon N.A. |
Composite with sodium starch glycolate as a support material and products thereof
|
|
US5861431A
(en)
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
|
AU6526896A
(en)
|
1995-07-22 |
1997-02-18 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
AUPN842196A0
(en)
|
1996-03-05 |
1996-03-28 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
GB9607219D0
(en)
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP2000510862A
(ja)
|
1996-05-24 |
2000-08-22 |
ニューロサーチ・アクティーゼルスカブ |
クロライドチャンネル遮断剤として有用なフエニル誘導体
|
|
EP0906273B1
(en)
|
1996-05-24 |
2002-10-16 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
|
CZ425698A3
(cs)
|
1996-06-27 |
1999-06-16 |
Smithkline Beecham Corporation |
Antagonista IL-8 receptoru
|
|
WO1998000016A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
|
|
US6063808A
(en)
|
1996-07-01 |
2000-05-16 |
Sepracor Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (S,S)-glycopyrrolate
|
|
FR2750988B1
(fr)
|
1996-07-11 |
1998-09-18 |
Adir |
Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP4863534B2
(ja)
|
1996-10-25 |
2012-01-25 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
可溶形態浸透用量送達システム
|
|
WO1998024785A1
(en)
|
1996-12-02 |
1998-06-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Indole-urea derivatives with 5-ht antagonist properties
|
|
US20010051719A1
(en)
|
1996-12-19 |
2001-12-13 |
Smithkline Beecham P.L.C. |
Novel compounds
|
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
DE59803962D1
(de)
|
1997-03-25 |
2002-06-06 |
Ciba Sc Holding Ag |
Polycyclische Verbindungen
|
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
SK282818B6
(sk)
|
1997-04-22 |
2002-12-03 |
Neurosearch A/S |
Substituované fenylderiváty, ich príprava, použitie a farmaceutický prípravok
|
|
CA2272291C
(en)
|
1997-04-22 |
2008-06-17 |
Janssen Pharmaceutica N.V. |
Crf antagonistic quino- and quinazolines
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
CZ296845B6
(cs)
|
1997-05-28 |
2006-07-12 |
Aventis Pharmaceuticals Inc. |
Derivát chinolinu a chinoxalinu, farmaceutický prostredek obsahující tento derivát a pouzití
|
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
|
US6103905A
(en)
|
1997-06-19 |
2000-08-15 |
Sepracor, Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
US6172084B1
(en)
|
1997-06-19 |
2001-01-09 |
Sepracor, Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
US6376670B1
(en)
|
1997-06-19 |
2002-04-23 |
Sepracor Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
PL338016A1
(en)
|
1997-07-11 |
2000-09-25 |
Smithkline Beecham Plc |
Novel chemical compounds
|
|
US6028083A
(en)
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
|
AU8673198A
(en)
|
1997-07-29 |
1999-02-22 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
NZ502990A
(en)
|
1997-08-27 |
2002-02-01 |
Hexal Ag |
Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
TR200001179T2
(tr)
|
1997-10-31 |
2000-11-21 |
Aventis Pharma Ltd. |
Değiştirilmiş anilidler
|
|
JPH11183942A
(ja)
|
1997-12-19 |
1999-07-09 |
Nippon Mitsubishi Oil Corp |
エレクトロクロミック素子
|
|
NZ505843A
(en)
|
1997-12-22 |
2003-06-30 |
Bayer Ag |
Diphenyl ureas compounds for treating cancer and raf kinase related diseases
|
|
DE69830513T2
(de)
|
1997-12-22 |
2006-03-16 |
Bayer Pharmaceuticals Corp., West Haven |
HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
GB9801392D0
(en)
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9803411D0
(en)
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6100291A
(en)
|
1998-03-16 |
2000-08-08 |
Allelix Biopharmaceuticals Inc. |
Pyrrolidine-indole compounds having 5-HT6 affinity
|
|
WO1999052927A1
(en)
|
1998-04-14 |
1999-10-21 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6251893B1
(en)
|
1998-06-15 |
2001-06-26 |
Nps Allelix Corp. |
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
|
|
US6140509A
(en)
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
GB9816263D0
(en)
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9818916D0
(en)
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9819384D0
(en)
|
1998-09-04 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds II
|
|
GB9819382D0
(en)
|
1998-09-04 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds I
|
|
GB9820113D0
(en)
|
1998-09-15 |
1998-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6358698B1
(en)
|
1998-10-07 |
2002-03-19 |
Acadia Pharmacueticals Inc. |
Methods of identifying inverse agonists of the serotonin 2A receptor
|
|
PL198852B1
(pl)
|
1998-10-22 |
2008-07-31 |
Neurosearch As |
Podstawione pochodne fenylu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
|
|
US6403808B1
(en)
|
1999-12-10 |
2002-06-11 |
Virginia Commonwealth University |
Selective 5-HT6 receptor ligands
|
|
US6150393A
(en)
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
|
JP2002534512A
(ja)
|
1999-01-15 |
2002-10-15 |
ノボ ノルディスク アクティーゼルスカブ |
非ペプチドｇｌｐ−１アゴニスト
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
RU2001129155A
(ru)
|
1999-03-26 |
2003-08-10 |
Еро-Сельтик С.А. (Lu) |
Соединения с арильными заместителями (варианты), фармацевтическая композиция и способ лечения расстройства, чувствительного к блокаде натриевых каналов у млекопитающего, способ лечения, профилактики различных заболеваний или уменьшения интенсивности гибели или потери нейронов (варианты), способ облегчения или предупреждения эпилептических припадков у животного (варианты), соединение - радиоактивный лиганд для участка связывания в натриевом канале
|
|
DE60004654T2
(de)
|
1999-03-29 |
2004-06-24 |
Neurogen Corp., Branford |
4-substituierte chinolinderivate als nk-3 und/oder gaba(a) rezeptor liganden
|
|
EP1173432B9
(en)
|
1999-04-21 |
2008-10-15 |
NPS Allelix Corp. |
Piperidine-indole compounds having 5-ht6 affinity
|
|
GB9909409D0
(en)
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
|
AU4802500A
(en)
|
1999-04-26 |
2000-11-10 |
Neurogen Corporation |
2-aminoquinolinecarboxamides: neurokinin receptor ligands
|
|
US6469006B1
(en)
|
1999-06-15 |
2002-10-22 |
Bristol-Myers Squibb Company |
Antiviral indoleoxoacetyl piperazine derivatives
|
|
IT1312115B1
(it)
|
1999-06-24 |
2002-04-04 |
Nicox Sa |
Composti amorfi e relative composizioni farmaceutiche
|
|
EP1208097B1
(en)
|
1999-07-28 |
2009-02-18 |
Aventis Pharmaceuticals Inc. |
Substituted oxoazaheterocyclyl compounds
|
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
|
GB9926302D0
(en)
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
AU1542201A
(en)
|
1999-11-05 |
2001-05-14 |
Nps Allelix Corp. |
Compounds having 5-HT6 receptor antagonist activity
|
|
US6531291B1
(en)
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
|
UA75055C2
(uk)
|
1999-11-30 |
2006-03-15 |
Пфайзер Продактс Інк. |
Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
|
|
EP1108720A1
(en)
|
1999-12-08 |
2001-06-20 |
Basf Aktiengesellschaft |
Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
|
|
EP1248770A1
(en)
|
1999-12-16 |
2002-10-16 |
Biostream Therapeutics |
1,3,4-substituted piperidine analogs and uses thereof in treating addictions
|
|
EP1242398A2
(en)
|
1999-12-20 |
2002-09-25 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
|
AU2001241927A1
(en)
|
2000-02-28 |
2001-09-12 |
Scios Inc. |
Inhibitors of p38-alpha kinase
|
|
US6310212B1
(en)
|
2000-03-28 |
2001-10-30 |
Neurogen Corporation |
4-substituted quinoline derivatives
|
|
PE20020063A1
(es)
|
2000-06-20 |
2002-01-30 |
Upjohn Co |
Bis-arilsulfonas como ligandos del receptor de 5-ht
|
|
FR2810979B1
(fr)
|
2000-06-29 |
2002-08-23 |
Adir |
Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
SE0002754D0
(sv)
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New pharmaceutical combination formulation and method of treatment with the combination
|
|
GB0021450D0
(en)
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
SK5212003A3
(en)
|
2000-10-02 |
2004-03-02 |
Janssen Pharmaceutica Nv |
Metabotropic glutamate receptor antagonists
|
|
NZ524675A
(en)
|
2000-10-20 |
2004-09-24 |
Biovitrum Ab |
2-, 3-, 4-, or 5-substituted-N1-(benzensulfonyl) indoles and their use in therapy
|
|
DE10053813A1
(de)
|
2000-10-30 |
2002-05-08 |
Bayer Ag |
Neue Verwendung von Sulfonamiden
|
|
WO2002036562A2
(en)
|
2000-11-02 |
2002-05-10 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
WO2002042293A1
(en)
|
2000-11-21 |
2002-05-30 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of cns disorders
|
|
EP1335722B1
(en)
|
2000-11-24 |
2006-08-30 |
Smithkline Beecham Plc |
Indolyl-sulfonyl- compounds useful in the treatment of cns disorders
|
|
ES2188344B1
(es)
|
2000-11-29 |
2004-09-16 |
Laboratorios Vita, S.A. |
Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
|
|
AR035521A1
(es)
|
2000-12-22 |
2004-06-02 |
Lundbeck & Co As H |
Derivados de 3-indolina y composicion farmaceutica que los comprende
|
|
EP1351936A1
(en)
|
2001-01-15 |
2003-10-15 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
|
US20020156068A1
(en)
|
2001-03-22 |
2002-10-24 |
Behan Dominic P. |
Anti-psychosis combination
|
|
CA2442114C
(en)
|
2001-03-29 |
2011-06-21 |
Eli Lilly And Company |
N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
|
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
PL367305A1
(en)
|
2001-06-07 |
2005-02-21 |
F.Hoffmann-La Roche Ag |
New indole derivatives with 5-ht6 receptor affinity
|
|
JP2005501019A
(ja)
|
2001-06-15 |
2005-01-13 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６レセプター親和性を有する４−ピペラジニルインドール誘導体
|
|
ITRM20010356A1
(it)
|
2001-06-21 |
2002-12-23 |
Sigma Tau Ind Farmaceuti |
"5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
|
|
AU2002321061B2
(en)
|
2001-06-29 |
2006-08-24 |
Eurand Pharmaceuticals Ltd |
Process of thermodynamical activation of water-insoluble drugs loaded into cross linked polymers
|
|
EP1411925A1
(en)
|
2001-08-03 |
2004-04-28 |
PHARMACIA & UPJOHN COMPANY |
5-arylsulfonyl indoles having 5-ht6 receptor affinity
|
|
EP1414442A1
(en)
|
2001-08-07 |
2004-05-06 |
Smithkline Beecham Plc |
3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
|
|
RU2268884C2
(ru)
|
2001-08-10 |
2006-01-27 |
Ф.Хоффманн-Ля Рош Аг |
Арилсульфонильные производные, обладающие сродством к рецептору 5-ht6, и способ их получения
|
|
JP4733877B2
(ja)
|
2001-08-15 |
2011-07-27 |
富士通セミコンダクター株式会社 |
半導体装置
|
|
EP2305656B1
(en)
|
2001-08-31 |
2012-10-24 |
Novartis AG |
Optical isomers of an iloperidone metabolite
|
|
AU2002341693B2
(en)
|
2001-09-21 |
2008-05-29 |
Bristol-Myers Squibb Holdings Ireland Unlimited Company |
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
|
|
JP2005506368A
(ja)
|
2001-10-23 |
2005-03-03 |
ビオヴィトルム・アクチボラゲット |
肥満の処置におけるまたは食物摂取の減少のためのインドールおよびインドリン誘導体の使用
|
|
SE0103649D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinoline compounds
|
|
WO2003062205A1
(en)
|
2001-12-21 |
2003-07-31 |
Smithkline Beecham P.L.C. |
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
|
|
WO2003062206A2
(en)
|
2002-01-23 |
2003-07-31 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
GB0202679D0
(en)
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2003244452A1
(en)
|
2002-02-05 |
2003-09-02 |
Glaxo Group Limited |
Method of promoting neuronal growth
|
|
JP2005522452A
(ja)
|
2002-02-13 |
2005-07-28 |
グラクソ グループ リミテッド |
Ｃｎｓ疾患の治療のための、５−ｈｔ６受容体アフィニティーを有する７−アリールスルホンアミド−２，３，４，５−テトラヒドロ−１ｈ−ベンゾ’ジアゼピン誘導体
|
|
BR0307903A
(pt)
|
2002-02-22 |
2006-04-04 |
Upjohn Co |
derivados de arilsulfona
|
|
AR039127A1
(es)
|
2002-03-27 |
2005-02-09 |
Glaxo Group Ltd |
Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
|
|
AU2003226724A1
(en)
|
2002-03-27 |
2003-10-08 |
Glaxo Group Limited |
Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
|
|
ES2256744T3
(es)
|
2002-05-13 |
2006-07-16 |
F. Hoffmann-La Roche Ag |
Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos.
|
|
AU2003298514A1
(en)
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
AU2003237705B2
(en)
|
2002-06-05 |
2009-07-30 |
F. Hoffmann-La Roche Ag |
1-sulfonyl-4-aminoalkoxy indole derivatives as 5-HT6-receptor modulators for the treatment of CNS-disorders
|
|
SG156524A1
(en)
|
2002-06-20 |
2009-11-26 |
Biovitrum Ab Publ |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
|
US7943639B2
(en)
|
2002-06-20 |
2011-05-17 |
Proximagen Limited |
Compounds
|
|
WO2004026830A1
(en)
|
2002-09-17 |
2004-04-01 |
F. Hoffmann-La Roche Ag |
2,7-substituted indoles and their use as 5-ht6 modulators
|
|
NZ538047A
(en)
|
2002-09-17 |
2007-10-26 |
Hoffmann La Roche |
2,4-substituted indoles and their use as 5-HT6 modulators
|
|
AU2003275093A1
(en)
|
2002-09-24 |
2004-04-19 |
Arena Pharmaceuticals, Inc. |
Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
|
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
|
RU2324693C2
(ru)
|
2002-10-18 |
2008-05-20 |
Ф.Хоффманн-Ля Рош Аг |
4-пиперазинилбензолсульфонилиндолы, характеризующиеся сродством к рецептору 5-нт6
|
|
BR0315302A
(pt)
|
2002-11-08 |
2005-08-23 |
Hoffmann La Roche |
Benzoxazinonas substituìdas e seus usos
|
|
TW200735568A
(en)
|
2002-11-08 |
2007-09-16 |
Interdigital Tech Corp |
Composite channel quality estimation techniques for wireless receivers
|
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
|
CA2508315A1
(en)
|
2002-12-03 |
2004-06-17 |
F. Hoffmann-La Roche Ag |
Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
|
|
WO2004058722A1
(en)
|
2002-12-24 |
2004-07-15 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US7601740B2
(en)
*
|
2003-01-16 |
2009-10-13 |
Acadia Pharmaceuticals, Inc. |
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
|
|
WO2004071426A2
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
|
EP1592389B1
(en)
|
2003-02-14 |
2009-04-22 |
Laboratoires Serono SA |
Piperazine-2-carboxamide derivatives
|
|
EP1592683A2
(en)
|
2003-02-14 |
2005-11-09 |
Wyeth |
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
|
|
TW200418830A
(en)
|
2003-02-14 |
2004-10-01 |
Wyeth Corp |
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
JP2006515341A
(ja)
|
2003-03-03 |
2006-05-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６調節物質として使用するための２，５−および２，６−置換テトラヒドロイソキノリン
|
|
TWI289141B
(en)
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
GB0305575D0
(en)
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
MXPA05010496A
(es)
|
2003-03-28 |
2005-11-16 |
Pharmacia & Upjohn Co Llc |
Moduladores alostericos positivos del receptor de acetilcolina nicotinico.
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
EP1695966A1
(en)
|
2003-07-22 |
2006-08-30 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
RS20060035A
(sr)
|
2003-07-22 |
2008-08-07 |
Arena Pharmaceuticals Inc., |
Derivati diaril i arilheteroaril uree kao modulatori receptora 5-ht2a serotonina korisni u profilaksi i lečenju poremećaja u vezi sa njima
|
|
US7514438B2
(en)
|
2003-08-13 |
2009-04-07 |
Amgen, Inc. |
Melanin concentrating hormone receptor antagonist
|
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
|
GB0320320D0
(en)
|
2003-08-29 |
2003-10-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US20050054691A1
(en)
|
2003-08-29 |
2005-03-10 |
St. Jude Children's Research Hospital |
Carboxylesterase inhibitors
|
|
CA2537364A1
(en)
|
2003-09-03 |
2005-03-10 |
Galapagos Nv |
Imidazo[1,5-a]pyridine or imidazo[1,5-a]piperidine derivatives and their use for the preparation of medicament against 5-ht2a receptor-related disorders
|
|
GB0321473D0
(en)
|
2003-09-12 |
2003-10-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0322510D0
(en)
|
2003-09-25 |
2003-10-29 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0322629D0
(en)
|
2003-09-26 |
2003-10-29 |
Glaxo Group Ltd |
Novel compound
|
|
SE0302760D0
(sv)
|
2003-10-20 |
2003-10-20 |
Biovitrum Ab |
New compounds
|
|
WO2005066157A1
(en)
|
2004-01-02 |
2005-07-21 |
Suven Life Sciences |
3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
US20070293539A1
(en)
*
|
2004-03-18 |
2007-12-20 |
Lansbury Peter T |
Methods for the treatment of synucleinopathies
|
|
WO2005103011A1
(en)
|
2004-03-23 |
2005-11-03 |
Arena Pharmaceuticals, Inc. |
Processes for preparing substituted n-aryl-n’-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
|
|
GB0407025D0
(en)
|
2004-03-29 |
2004-04-28 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0411421D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
ATE412651T1
(de)
|
2004-06-09 |
2008-11-15 |
Glaxo Group Ltd |
Pyrrolopyridinderivate
|
|
US20060014705A1
(en)
|
2004-06-30 |
2006-01-19 |
Howitz Konrad T |
Compositions and methods for selectively activating human sirtuins
|
|
TW200616608A
(en)
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
|
US20080261952A1
(en)
|
2004-08-16 |
2008-10-23 |
Jason Bloxham |
Aryl Urea Derivatives for Treating Obesity
|
|
US20060063754A1
(en)
|
2004-09-21 |
2006-03-23 |
Edgar Dale M |
Methods of treating a sleep disorder
|
|
GB0422263D0
(en)
|
2004-10-07 |
2004-11-10 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2332527A3
(en)
|
2004-10-20 |
2011-11-16 |
Resverlogix Corp. |
Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
|
|
EP1804785A2
(en)
|
2004-10-27 |
2007-07-11 |
Neurogen Corporation |
Diaryl ureas as cb1 antagonists
|
|
WO2006049734A2
(en)
|
2004-10-29 |
2006-05-11 |
Hypnion, Inc. |
Quetiapine analogs and methods of use thereof
|
|
KR101358078B1
(ko)
|
2004-11-01 |
2014-02-06 |
주식회사 유스팜인터내셔널 |
근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
|
|
GB0425548D0
(en)
|
2004-11-19 |
2004-12-22 |
Glaxo Group Ltd |
Radiolabelled ligands
|
|
PE20061130A1
(es)
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2006060654A2
(en)
|
2004-12-01 |
2006-06-08 |
Divergence, Inc. |
Pesticidal compositions and methods
|
|
US20080015223A1
(en)
|
2004-12-03 |
2008-01-17 |
Arena Pharmaceuticals, Inc. |
Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
|
|
DE102004061593A1
(de)
|
2004-12-21 |
2006-06-22 |
Abbott Gmbh & Co. Kg |
Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
|
|
EP1831172B1
(en)
|
2004-12-28 |
2009-02-18 |
Council of Scientific and Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
|
PL1858877T3
(pl)
|
2005-01-14 |
2014-08-29 |
Gilead Connecticut Inc |
1,3 podstawione diarylem moczniki jako modulatory aktywności kinazy
|
|
EP1843762A1
(en)
|
2005-01-19 |
2007-10-17 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
|
EP1683516B1
(en)
|
2005-01-21 |
2010-06-02 |
Teva Pharmaceutical Industries Ltd |
Stable pharmaceutical formulations of zonisamide and methods for their manufacture
|
|
AR052886A1
(es)
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
|
CA2595170C
(en)
|
2005-01-27 |
2014-08-05 |
Janssen Pharmaceutica N.V. |
Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
|
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
EP1853590A1
(en)
|
2005-03-03 |
2007-11-14 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505437D0
(en)
|
2005-03-17 |
2005-04-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505725D0
(en)
|
2005-03-19 |
2005-04-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
|
US7494998B2
(en)
|
2005-04-26 |
2009-02-24 |
Hypnion, Inc. |
Benzisoxazole piperazine compounds and methods of use thereof
|
|
EP1734039A1
(en)
|
2005-06-13 |
2006-12-20 |
Esbatech AG |
Aryl urea compounds as BETA-secretase inhibitors
|
|
NZ564916A
(en)
|
2005-06-27 |
2011-03-31 |
Exelixis Inc |
Imidazole based LXR modulators
|
|
US7754724B2
(en)
|
2005-06-30 |
2010-07-13 |
Dow Agrosciences Llc |
N-substituted piperazines
|
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US7544685B2
(en)
|
2005-08-17 |
2009-06-09 |
H. Lundbeck A/S |
2,3-dihydroindole compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
GB0519765D0
(en)
|
2005-09-28 |
2005-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0519760D0
(en)
|
2005-09-28 |
2005-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0519758D0
(en)
|
2005-09-28 |
2005-11-09 |
Glaxo Group Ltd |
Novel process
|
|
EA200800971A1
(ru)
|
2005-09-29 |
2008-08-29 |
Арена Фармасьютикалз, Инк. |
Фармацевтические композиции модулятора 5-нтрецепторов серотонина, полезные в лечении связанных с ними нарушений
|
|
PE20071143A1
(es)
|
2006-01-13 |
2008-01-20 |
Wyeth Corp |
Composicion farmaceutica que comprende un inhibidor de acetilcolinesterasa y un antagonista 5-hidroxitriptamina-6
|
|
WO2007103286A2
(en)
|
2006-03-02 |
2007-09-13 |
Spherics, Inc. |
Rate-controlled bioadhesive oral dosage formulations
|
|
EP2004627A2
(en)
|
2006-04-10 |
2008-12-24 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
GB0608655D0
(en)
|
2006-05-03 |
2006-06-14 |
Merck Sharp & Dohme |
Therapeutic Treatment
|
|
EP2051978A2
(en)
|
2006-05-18 |
2009-04-29 |
Arena Pharmaceuticals, Inc. |
Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
MX349156B
(es)
|
2006-05-18 |
2017-07-14 |
Arena Pharm Inc |
Formas cristalinas y procesos para la preparacion de fenil-pirazoles utiles como moduladores del receptor de serotonina 5-ht2a.
|
|
ES2536762T3
(es)
|
2006-05-18 |
2015-05-28 |
Arena Pharmaceuticals, Inc. |
Aminas primarias y sus derivados como moduladores del receptor de la serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con este
|
|
CN101479261A
(zh)
|
2006-05-18 |
2009-07-08 |
艾尼纳制药公司 |
3-吡唑基-苯甲酰胺-4-醚、其仲胺及其衍生物作为5-ht2a血清素受体的调节剂用于治疗与其相关的病症
|
|
EP2040755B1
(en)
|
2006-06-23 |
2011-05-18 |
Laboratorios Del. Dr. Esteve, S.A. |
Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
|
|
JP2010502618A
(ja)
|
2006-08-31 |
2010-01-28 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
セロトニン５−ｈｔ２ａ受容体のモジュレータとしてのベンゾフラン誘導体
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
TW200823204A
(en)
|
2006-10-17 |
2008-06-01 |
Arena Pharm Inc |
Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
|
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
US8097633B2
(en)
|
2006-11-15 |
2012-01-17 |
Rich Steven A |
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
|
|
US8969402B2
(en)
|
2006-11-15 |
2015-03-03 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
US9034890B2
(en)
|
2006-11-15 |
2015-05-19 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
KR20090094125A
(ko)
|
2006-12-08 |
2009-09-03 |
엑셀리시스, 인코포레이티드 |
Ｌｘｒ 및 ｆｘｒ 조절자
|
|
WO2008113818A1
(en)
|
2007-03-21 |
2008-09-25 |
Glaxo Group Limited |
Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
|
|
EP2190844B3
(en)
|
2007-08-15 |
2013-07-17 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
NO2200610T3
(OSRAM)
|
2007-09-21 |
2018-06-09 |
|
|
|
EP2508177A1
(en)
|
2007-12-12 |
2012-10-10 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US20110178094A1
(en)
|
2008-10-03 |
2011-07-21 |
H. Lundbeck A/S |
Oral Formulation
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
RS57110B1
(sr)
|
2008-10-28 |
2018-06-29 |
Arena Pharm Inc |
Sastavi modulatora 5-ht2a serotoninskog receptora korisni za tretiranje poremećaja povezanih sa njim
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
CA2850707C
(en)
|
2011-10-03 |
2023-03-21 |
The University Of Utah Research Foundation |
Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
|
|
SG11201408240TA
(en)
*
|
2012-06-11 |
2015-01-29 |
Psychogenics Inc |
Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
|
|
JO3459B1
(ar)
|
2012-09-09 |
2020-07-05 |
H Lundbeck As |
تركيبات صيدلانية لعلاج مرض الزهايمر
|
|
JOP20210047A1
(ar)
|
2012-10-25 |
2017-06-16 |
Otsuka Pharma Co Ltd |
عامل وقائي و/أو علاجي للأعراض السلوكية والنفسية المصحوبة بمرض تنكسي عصبي أو الأعراض الإندفاعية المصحوبة بمرض ذهني، يحتوي على بريكسبيرازول أو ملحه
|
|
WO2014085362A1
(en)
|
2012-11-27 |
2014-06-05 |
Acadia Pharmaceuticals Inc. |
Methods for the treatment of parkinson's disease psychosis using pimavanserin
|
|
KR101472682B1
(ko)
|
2013-07-23 |
2014-12-15 |
고려대학교 산학협력단 |
메타물질 제조 방법, 이에 의해 제조된 메타물질 구조 필름 및 이를 이용한 광학 이미징 시스템
|
|
IL321987A
(en)
*
|
2013-12-03 |
2025-09-01 |
Intra Cellular Therapies Inc |
A long-acting injectable preparation containing polymeric microspheres of modified compressed gamma-carboline heterocyclic compounds or a sustained-release pharmaceutical preparation containing these compounds for use in the treatment of bipolar I and/or bipolar II disorders
|
|
US9478471B2
(en)
|
2014-02-19 |
2016-10-25 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Apparatus and method for verification of bonding alignment
|
|
US20150313903A1
(en)
|
2014-05-05 |
2015-11-05 |
Ovid Therapeutics Inc. |
Methods of treating cognitive impairment associated with neurodegenerative disorders
|
|
EP3291816A4
(en)
|
2015-05-07 |
2019-01-02 |
Axovant Sciences GmbH |
Compositions and methods of treating a neurodegenerative disease
|
|
US20160324851A1
(en)
|
2015-05-07 |
2016-11-10 |
Axovant Sciences, Ltd. |
Methods of treating a neurodegenerative disease
|
|
AU2016276966A1
(en)
|
2015-06-12 |
2018-01-18 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder
|
|
EP3322415A4
(en)
|
2015-07-15 |
2019-03-13 |
Axovant Sciences GmbH |
DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR FOR PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS RELATED TO A NEUROGENERATIVE DISEASE
|
|
WO2018148737A1
(en)
|
2017-02-13 |
2018-08-16 |
Axovant Sciences Gmbh |
5-ht2a serotonin receptor serotonin receptor inverse agonists useful for the prophylaxis and treatment of parkinsonian symptoms associated with a neurodegenerative disease
|
|
WO2019033068A1
(en)
|
2017-08-10 |
2019-02-14 |
Axovant Sciences Gmbh |
USE OF INVERSE AGONISTS OF 5 HT2A FOR THE TREATMENT OF PSYCHOSES
|